News | February 27, 2025
Senores Pharmaceuticals begins operations at greenfield API facility
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
the inspection conducted from January 27 to January 31, 2025
Observations are largely around improvement of procedures and practices
The Alathur facility specializes in the production of Cephalosporin antibiotics
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
The inspection was carried out from January 28 to February 1, 2025
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
OneSource operates five cGMP facilities and has a strong track record, with 138 successful regulatory and customer audits to date by all major regulatory bodies
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations
Subscribe To Our Newsletter & Stay Updated
